Skip to main content
Signal8

Elixxer Ltd. (ELIXF)

Elixxer Ltd. operates as an investment company specifically focused on the cannabis industry. This firm strategically deploys capital into fully licensed businesses engaged in the cultivation, production, and sale of medicinal and specialized cannabis, as well as cannabis-derived products, predominantly for the pharmaceutical sector. Its investment reach extends across Canada, Australia, Italy, Jamaica, and Switzerland. Founded in 2004, the Montreal, Canada-based company adopted its current name, Elixxer Ltd., in August 2019, having previously been known as LGC Capital Ltd.

Sector: Drug Manufacturers - Specialty & Generic

Industry: Drug Manufacturers - Specialty & Generic

Elixxer Ltd. logo

Elixxer Ltd.

OTC:ELIXFHealthcare
CLOSED
Mkt Cap-
EV-
Float14.68M
O/S95.26M
VOL714 sh
Inst Own-
SI0.1%
Net Cash/Sh-
Dilution
FormDescription
    Elixxer Ltd. (ELIXF) SEC Filings: 10-K, 10-Q, 8-K, Form 4 | Signal8